https://doctransparency.com/specialty/gastroenterology/fl
State Specialty Directory

Gastroenterology in FL

Federal CMS data for 1225 gastroenterology providers across FL. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.

1225
Providers
Median industry payments
$2,552
1225
Gastroenterology Providers
in FL
$2,552
Median Industry Payments
per provider (2018–2024)
416
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only Medicare fee-for-service patients (typically 65+). This does not represent total practice volume. Industry payments span multiple years and payment types — they are legal and do not indicate wrongdoing. Gastroenterology includes multiple subspecialties with different practice patterns. Learn more →
Showing top 50 of 1225 providers, ranked by Medicare service volume. Search by city to narrow results.

Gastroenterology Providers — FL

NPPES · Open Payments · Medicare
ProviderCityMedicare VolumeBeneficiaries*Top ProcedureIndustry PaymentsPayment TypeCoverage
HIRTH, MOSHE M.D.DELRAY BEACH51,0744,191Vedolizumab infusion (Entyvio)$4,137 (2018-2024)Food & Beverage (96%) Very High
NAUS, MORRIS M.D.DELRAY BEACH37,9502,005Vedolizumab infusion (Entyvio)$198,703 (2018-2024)Consulting (63%) Very High
ELLIS, ELLIOT M.D.WEST PALM BEACH32,6562,444Vedolizumab infusion (Entyvio)$4,850 (2018-2024)Food & Beverage (99%) Very High
AL-SHURIEKI, SAMER MDPENSACOLA30,7211,667Vedolizumab infusion (Entyvio)$5,951 (2018-2024)Food & Beverage (100%) Very High
SNINSKY, CHARLES MDGAINESVILLE25,7501,055Vedolizumab infusion (Entyvio)$974,609 (2018-2024)Consulting (88%) Very High
KONDAPALLI, RAVI M.D.VENICE25,3182,612Vedolizumab infusion (Entyvio)$26,691 (2018-2024)Consulting (49%) Very High
AL-AZZAWI, YASIR MDDELRAY BEACH23,488796Vedolizumab infusion (Entyvio)$4,663 (2019-2024)Food & Beverage (92%) Very High
CAVELL, LIANNE MDDELRAY BEACH22,3281,192Vedolizumab infusion (Entyvio)$7,550 (2018-2024)Food & Beverage (98%) Very High
DUMAS, PETER MDVENICE20,7081,433Vedolizumab infusion (Entyvio)$11,447 (2018-2024)Food & Beverage (92%) Very High
CORREGIDOR, ANA MDJACKSONVILLE18,5211,173Vedolizumab infusion (Entyvio)$47,795 (2018-2024)Consulting (82%) Very High
SOUTHERLAND, JOHN M.D.SARASOTA17,9111,560Vedolizumab infusion (Entyvio)$13,562 (2018-2024)Food & Beverage (97%) Very High
LEVY, RONALD MDLAKE WORTH16,969904Vedolizumab infusion (Entyvio)$6,567 (2018-2024)Food & Beverage (91%) Very High
SANCHEZ, NYDIA MDJACKSONVILLE16,5481,048Vedolizumab infusion (Entyvio)$4,618 (2018-2024)Food & Beverage (100%) Very High
CHAU, ANHTUNG MDJACKSONVILLE15,5731,250Vedolizumab infusion (Entyvio)$1,039 (2018-2024)Food & Beverage (100%) Very High
MUNOZ, JUAN MDJACKSONVILLE15,435926Vedolizumab infusion (Entyvio)$741 (2018-2024)Food & Beverage (100%) Very High
LOEWE, CHARLES MDSARASOTA15,4111,236Vedolizumab infusion (Entyvio)$98,595 (2018-2024)Consulting (53%) Very High
DAWSON, MARK BRADENTON14,9721,371Vedolizumab infusion (Entyvio)$8,434 (2018-2024)Food & Beverage (98%) Very High
AGNELLO, KATIE M.D.VENICE14,4301,232Vedolizumab infusion (Entyvio)$12,685 (2018-2024)Food & Beverage (92%) Very High
AXLEY, PAGE M.D.PENSACOLA13,381855Vedolizumab infusion (Entyvio)$1,898 (2020-2024)Food & Beverage (100%) Very High
SCHWIMMER, DAVID M.D.PALM BEACH GARDENS13,242877Vedolizumab infusion (Entyvio)$9,645 (2018-2024)Food & Beverage (90%) Very High
MUSOFF, ROY MDDELRAY BEACH11,2489,092Office visit, established patient (20-29 min)$66 (2018-2023)Food & Beverage (100%) Very High
HOOGERWERF, WILLEMIJNTJE MDST AUGUSTINE10,5541,317Vedolizumab infusion (Entyvio)$7,947 (2018-2024)Food & Beverage (100%) Very High
ROSS, JASON MDJACKSONVILLE10,3921,040Vedolizumab infusion (Entyvio)$1,693 (2018-2024)Food & Beverage (100%) Very High
KATZ, BARRY MDALTAMONTE SPRINGS9,8641,500Vedolizumab infusion (Entyvio)$12,393 (2018-2024)Food & Beverage (100%) Very High
BASKAR, SOUNDARAPANDIAN MDTAVARES9,1386,239Tissue pathology examination, moderate complexity$5,017 (2018-2024)Food & Beverage (99%) Very High
KHAZANCHI, ARUN MDLAKEWOOD RANCH8,9561,645Vedolizumab infusion (Entyvio)$7,057 (2018-2024)Food & Beverage (98%) Very High
EISNER, TODD MDBOCA RATON8,8113,419Tissue pathology examination, moderate complexity$3,912 (2018-2024)Food & Beverage (94%) Very High
TRAN, LILY M.DLEESBURG8,5683,471Tissue pathology examination, moderate complexity$10,441 (2018-2024)Food & Beverage (100%) Very High
REILLY, PATRICK MDPENSACOLA8,150985Vedolizumab infusion (Entyvio)$6,233 (2018-2024)Food & Beverage (84%) Very High
ROSTHOLDER, EMILY M.D.JACKSONVILLE6,8121,272Vedolizumab infusion (Entyvio)$4,288 (2018-2024)Food & Beverage (97%) Very High
NAGABHAIRU, LALBAHADUR MDMOUNT DORA6,7254,649Hospital follow-up visit, moderate complexity$705 (2018-2024)Food & Beverage (97%) Very High
DOBHAN, RICHARD M.D.PENSACOLA6,631966Vedolizumab infusion (Entyvio)$2,705 (2018-2024)Food & Beverage (100%) Very High
KAPLAN, JONATHAN M.D.DELRAY BEACH6,2761,278Vedolizumab infusion (Entyvio)$17,694 (2018-2024)Food & Beverage (98%) Very High
MECKSTROTH, STEVEN M.D.NAPLES6,2684,547Tissue pathology examination, moderate complexity$8,614 (2018-2024)Food & Beverage (98%) Very High
MELLMAN, ROBERT MDBOCA RATON6,1653,077Office visit, established patient (30-39 min)$543 (2018-2024)Food & Beverage (89%) Very High
PROSCIA, VITO MDBOCA RATON5,99799Inclisiran injection (Leqvio) for cholesterol$1,485 (2018-2022)Food & Beverage (100%) Very High
ABITBOL, PROSPER DOBOCA RATON5,7772,398Tissue pathology examination, moderate complexity$6,982 (2018-2024)Food & Beverage (96%) Very High
AHMADI, BAHRAM MDSEBRING5,7423,297Hospital follow-up visit, high complexity$15,313 (2018-2024)Food & Beverage (83%) Very High
SEELA, SRINIVAS MDORLANDO5,2991,268Hospital follow-up visit, moderate complexity$3,705 (2018-2024)Food & Beverage (100%) Very High
GUPTA, VISHAL MDORANGE CITY5,2782,600Tissue pathology examination, moderate complexity$14,411 (2018-2024)Consulting (51%) Very High
RAMAIAH, BHARATHI MDTAVARES5,1233,207Tissue pathology examination, moderate complexity$2,804 (2018-2024)Food & Beverage (98%) Very High
SHEELA, HARINATH MDORLANDO5,1131,920Hospital follow-up visit, moderate complexity$7,089 (2018-2024)Food & Beverage (100%) Very High
GRACE, ALEXANDRA DO, MPHNAPLES5,0703,784Tissue pathology examination, moderate complexity$8,921 (2018-2024)Food & Beverage (99%) Very High
VERNACE, STEFANIA M.D.MIAMI5,019456Vedolizumab infusion (Entyvio)$1,171 (2018-2024)Food & Beverage (94%) Very High
CHANDRUPATLA, SREEKANTH M.D.CRYSTAL RIVER4,7213,022Tissue pathology examination, moderate complexity$8,943 (2018-2024)Food & Beverage (81%) Very High
TARUGU, VIKRAM M.DOKEECHOBEE4,4402,311Tissue pathology examination, moderate complexity$703 (2018-2024)Food & Beverage (100%) Very High
WELLS, CHRISTOPHER M.D.PANAMA CITY4,1783,536Office visit, established patient (30-39 min)$3,657 (2018-2024)Food & Beverage (67%) Very High
BIDANI, JATIN LARGO4,0492,142Tissue pathology examination, moderate complexity$3,714 (2018-2024)Food & Beverage (70%) Very High
SINGU, BHEEMA M.DOCALA3,9723,034Office visit, established patient (20-29 min)$5,115 (2018-2024)Food & Beverage (93%) Very High
HELLSTERN, PAUL M.D.CRYSTAL RIVER3,9712,842Office visit, established patient (20-29 min)$2,742 (2018-2024)Food & Beverage (98%) Very High
Note: Gastroenterology encompasses multiple subspecialties with different practice patterns. Differences in payment amounts and procedure volumes may reflect subspecialty focus rather than practice quality. Consider viewing individual profiles for full context.
Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →